$1.14
-0.05 (-4.20%)
Open$1.19
Previous Close$1.19
Day High$1.20
Day Low$1.14
52W High$9.00
52W Low$0.95
Volume—
Avg Volume270.8K
Market Cap44.54M
P/E Ratio—
EPS$-2.39
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+3,237.7% upside
Current
$1.14
$1.14
Target
$38.05
$38.05
$26.78
$38.05 avg
$46.02
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 12.33M | 11.14M | 10.37M |
| Net Income | -3,474,981 | -2,537,744 | -2,319,778 |
| Profit Margin | -28.2% | -22.8% | -22.4% |
| EBITDA | -5,324,397 | -5,017,327 | -4,875,631 |
| Free Cash Flow | -1,460,004 | -1,340,766 | -1,751,994 |
| Rev Growth | +17.2% | +1.6% | +25.0% |
| Debt/Equity | 0.34 | 0.29 | 0.35 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |